Lenz HJ - Search Results

1

Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab.

Innocenti F, Yazdani A, Rashid N, Qu X, Ou FS, Van Buren S, Bertagnolli MM, Kabbarah O, Blanke CD, Venook AP, Lenz HJ, Vincent BG. Innocenti F, et al. Among authors: lenz hj. Clin Cancer Res. 2022 Apr 14;28(8):1690-1700. doi: 10.1158/1078-0432.CCR-21-3202. Clin Cancer Res. 2022. PMID: 35176136 Free PMC article. Clinical Trial.

2

Molecular predictors of treatment and outcome in colorectal cancer.

Iqbal S, Lenz HJ. Iqbal S, et al. Among authors: lenz hj. Curr Gastroenterol Rep. 2003 Oct;5(5):399-405. doi: 10.1007/s11894-003-0053-3. Curr Gastroenterol Rep. 2003. PMID: 12959721 Review.

3

Tirapazamine plus carboplatin and paclitaxel in advanced malignant solid tumors: a california cancer consortium phase I and molecular correlative study.

Lara PN Jr, Frankel P, Mack PC, Gumerlock PH, Galvin I, Martel CL, Longmate J, Doroshow JH, Lenz HJ, Lau DH, Gandara DR. Lara PN Jr, et al. Among authors: lenz hj. Clin Cancer Res. 2003 Oct 1;9(12):4356-62. Clin Cancer Res. 2003. PMID: 14555506 Clinical Trial.

4

Irinotecan and paclitaxel in metastatic adenocarcinoma of the esophagus and gastric cardia.

Hecht JR, Blanke CD, Benson AB 3rd, Lenz HJ. Hecht JR, et al. Among authors: lenz hj. Oncology (Williston Park). 2003 Sep;17(9 Suppl 8):13-5. Oncology (Williston Park). 2003. PMID: 14569841 Free article.

5

SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibition.

Lara PN Jr, Quinn DI, Margolin K, Meyers FJ, Longmate J, Frankel P, Mack PC, Turrell C, Valk P, Rao J, Buckley P, Wun T, Gosselin R, Galvin I, Gumerlock PH, Lenz HJ, Doroshow JH, Gandara DR; California Cancer Consortium. Lara PN Jr, et al. Among authors: lenz hj. Clin Cancer Res. 2003 Oct 15;9(13):4772-81. Clin Cancer Res. 2003. PMID: 14581348 Clinical Trial.

6

Integration of novel agents in the treatment of colorectal cancer.

Iqbal S, Lenz HJ. Iqbal S, et al. Among authors: lenz hj. Cancer Chemother Pharmacol. 2004 Sep;54 Suppl 1:S32-9. doi: 10.1007/s00280-004-0884-0. Cancer Chemother Pharmacol. 2004. PMID: 15309512 Review.

7

Tailored chemotherapy for colorectal cancer: a new approach to therapy.

Iqbal S, Stoehlmacher J, Lenz HJ. Iqbal S, et al. Among authors: lenz hj. Cancer Invest. 2004;22(5):762-73. doi: 10.1081/cnv-200032774. Cancer Invest. 2004. PMID: 15581057 Review.

8

Angiogenesis inhibitors in the treatment of colorectal cancer.

Iqbal S, Lenz HJ. Iqbal S, et al. Among authors: lenz hj. Semin Oncol. 2004 Dec;31(6 Suppl 17):10-6. doi: 10.1053/j.seminoncol.2004.11.029. Semin Oncol. 2004. PMID: 15696025 Review.

9

Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation.

Zhang W, Park DJ, Lu B, Yang DY, Gordon M, Groshen S, Yun J, Press OA, Vallböhmer D, Rhodes K, Lenz HJ. Zhang W, et al. Among authors: lenz hj. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):600-5. Clin Cancer Res. 2005. PMID: 15701846

10

Molecular determinants of cetuximab efficacy.

Vallböhmer D, Zhang W, Gordon M, Yang DY, Yun J, Press OA, Rhodes KE, Sherrod AE, Iqbal S, Danenberg KD, Groshen S, Lenz HJ. Vallböhmer D, et al. Among authors: lenz hj. J Clin Oncol. 2005 May 20;23(15):3536-44. doi: 10.1200/JCO.2005.09.100. J Clin Oncol. 2005. PMID: 15908664

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

709 results

Search Page

Filters